SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
American Journal of Alzheimer's Disease and Other Dementias®
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Rebelo, S.
Right arrow Articles by da Cruz e Silva, O. A. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rebelo, S.
Right arrow Articles by da Cruz e Silva, O. A. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Monitoring ``De Novo'' APP Synthesis by Taking Advantage of the Reversible Effect of Cycloheximide

Sandra Rebelo, PhD

Laboratório de Neurociências Centro de Biologia Celular, Universidade de Aveiro, Aveiro, Portugal

Sandra Isabel Vieira, PhD

Laboratório de Neurociências Centro de Biologia Celular, Universidade de Aveiro, Aveiro, Portugal

Edgar F. da Cruz e Silva, PhD

Laboratorio de Transduçao de Sinais Centro de Biologia Celular, Universidade de Aveiro, Aveiro, Portugal

Odete A. B. da Cruz e Silva, PhD

Laboratório de Neurociências Centro de Biologia Celular, Universidade de Aveiro, Aveiro, Portugal, odetecs{at}ua.pt

By blocking ``de novo'' protein synthesis using cycloheximide, we previously described a dynamic model system to monitor turnover of a specific population of the Alzheimer's amyloid precursor protein. Here we show that cycloheximide is nontoxic and its effect is reversible, allowing protein synthesis to reinitiate. Upon cycloheximide removal protein synthesis restarted and by 1 hour the amyloid precursor protein— green fluorescent protein could be clearly detected, permitting the monitoring of amyloid precursor protein anterograde transport, particularly the secretory pathway. The consensus NPTY motif in amyloid precursor protein, typically associated with endocytosis, was mutated to NPTF or NPTE to mimic a constitutively dephosphorylated or phosphorylated residue, respectively. Our data reveal that disruption of this motif affects amyloid precursor protein endocytosis, as shown previously, but also its incorporation into trans-Golgi network budding vesicles. Thus, cycloheximide can be a useful tool to study both anterograde and retrograde ``in vivo'' protein transport.

Key Words: APP-GFP • phosphorylation • ``de novo'' pro-tein synthesis • monitoring • anterograde transport

American Journal of Alzheimer's Disease and Other Dementias®, Vol. 23, No. 6, 602-608 (2009)
DOI: 10.1177/1533317508323572


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement